Vinblastine, vincristine, vindesine and vinorelbine injections are for intravenous administration only. Inadvertent intrathecal administration can cause severe neurotoxicity, which is usually fatal.

• See individual trust policies for further details.

Vinblastine sulphate

• Solution for injection vials 10mg in 10ml (intravenous administration only)

Vincristine sulphate

• Solution for injection vials 1mg in 1ml, 2mg in 2ml (intravenous administration only)

Vindesine sulphate

• Powder for solution for injection vials 5mg (intravenous administration only)

Vinorelbine

• Capsules 20mg, 30mg, 80mg
• Concentrate for solution for infusion vials 10mg in 1ml, 50mg in 5ml (intravenous administration only)

Vinflunine

• NICE TA272: Vinflunine (Javlor) is not recommended within its marketing authorisation for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy (January 2013)